Eligochem
1 known investors
EligoChem designs and procures amphiphilic compound libraries for drug discovery, offering small molecules with improved absorption properties and reduced risk of off-target effects. The company also provides medicinal chemistry consultancy and screens compounds for lead identification and optimization with academic and research organizations.